Sie sind hier:


BCI colloquium 18th of October 2017

Dr. Alexander Crawford gave a lecture entitled "Microscale in vivo drug discovery using zebrafish models of human disease and drug safety"

Dr. Alexander Crawford

On Wednesday, 18th of October Dr. Alexander Crawford, Principal Investigator of the Chemical Biology Group at the Luxembourg Centre for Systems Biomedicine (Belval, Luxembourg), gave a great lecture about the zebra fish model for drug discovery. The following discussion was very fruitful.

Dr. Crawford is also the founding CEO of Theracule, a spin-off company focusing on personalized drug discovery and orphan drug development for genetic CNS disorders, and was the Project Manager of PharmaSea (2012-2017), a European Union-funded research consortium focusing on biodiscovery from marine microorganisms. Dr. Crawford was previously the founding CEO of two drug discovery companies in Germany, and held research positions at the Flanders Institute for Biotechnology (Leuven, Belgium) and the Whitehead Institute for Biomedical Research (Cambridge, Massachusetts). He earned a PhD in pharmaceutical sciences at the University of Leuven, an MPhil in neuroscience at the Max Planck Institute for Development Biology (Tübingen, Germany), and an SB in biology at the Massachusetts Institute of Technology.